D-0725-2026 Class II Ongoing

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

FDA drug recall D-0725-2026 was initiated by Fresenius Kabi USA, LLC on Jul 16, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter: Hair was found in product The recall status is ongoing. Affected quantity: 59,425 vials.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
59,425 vials

Product description

Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07

Reason for recall

Presence of Particulate Matter: Hair was found in product

Distribution pattern

Nationwide within in the USA

Code information

Lot #: 6134349, 6134620 Exp. Date 11/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0725-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0725-2026. Report a data issue: hello@regdatalab.com.